New BioMedicine Event-based Healthcare Investment Reports http://www.NewBioMedicine.com Is an event-based research report in the Healthcare sector (Biotechnology, Pharmaceutical, Medical Devices) that focuses on a specific event and provides an opinion (Positive or Negative) on the expected outcome of that event. In addition to the rationale behind the opinion, the analysis in the report covers vital features of the event-specific drug/device, the other competing products, the disease market, the sales forecasts/history (when applicable) and the pertinent details of the company developing the drug/device. INVESTMENT RATIONALE Price movements of the small-cap and mid-cap Biotech/Pharma companies are typically Event-driven rather than Earnings-driven (since most of them usually do not have any earnings).Thus, noteworthy news on any of the company’s key existing/pipeline products generally results in a significant move in the respective stock price (and often in related companies). UNIQUE SELLING POINT In addition to the high accuracy rate of predicting the outcome of the healthcare events, our reports aim to take very complex concepts in the medical realm and explain them in a very simple and concise manner to enable every potential investor to comprehend these concepts easily and clearly. Cutting-edge investment ideas in the Biotechnology and Pharmaceutical Industry. REGISTER NOW to receive $20 worth of FREE credit. This offer is validfor limited time only. http://www.NewBioMedicine.com

1. NewBioMedicine
Event-basedHealthcare InvestmentReports
http://www.NewBioMedicine.comIsanevent-basedresearchreportinthe Healthcare sector
(Biotechnology,Pharmaceutical,Medical Devices) thatfocusesonaspecificeventandprovidesan
opinion (Positive orNegative) onthe expectedoutcome of thatevent.Inadditiontothe rationale
behindthe opinion,the analysisinthe reportcoversvital featuresof the event-specific
drug/device,the othercompetingproducts,the diseasemarket,the salesforecasts/history(when
applicable) andthe pertinentdetailsof the companydevelopingthe drug/device.
INVESTMENTRATIONALE
Price movementsof the small-capandmid-capBiotech/Pharmacompaniesare typicallyEvent-
drivenratherthanEarnings-driven(since mostof themusuallydonothave anyearnings).Thus,
noteworthynewsonanyof the company’skeyexisting/pipelineproductsgenerallyresultsina
significantmove inthe respectivestockprice (andofteninrelatedcompanies).
UNIQUE SELLING POINT
In additiontothe highaccuracy rate of predictingthe outcome of the healthcare events,our
reportsaimto take verycomplex conceptsinthe medical realmandexplaintheminaverysimple
and concise mannertoenable everypotential investortocomprehend theseconceptseasilyand
clearly.
Cutting-edgeinvestmentideasinthe BiotechnologyandPharmaceutical Industry.REGISTERNOW
to receive $20 worthof FREE credit.Thisofferisvalidforlimitedtime only.
http://www.NewBioMedicine.com